Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Sosei Group Corporation announces it has dosed the first subject in a Phase trial evaluating its novel EP receptor agonist HTL for the treatment of Inflammatory Bowel Disease
Antengene Corporation Limited a leading innovative commercialstage global biopharmaceutical company dedicated to discovering developing and commercializing firstinclass
XTL Biopharmaceuticals Ltd announced today that it has entered into a binding term sheet with THE SOCIAL PROXY Ltda cutting edge web data company developing and powering a unique ethical IP based proxy and data extraction platform for AI BI Applicat...
Genomicsfocused biomedical research breakthroughs in cancer inherited eye disease and common gynaecological disorders are set to be accelerated by a million funding boost
Switzerlandbased CARBOGEN AMCIS a pharmaceutical process development and Active Pharmaceutical Ingredient manufacturing company announces the successful completion of its first Brazilian Regulatory Authority Agency routine inspection of its facility...
LIB Therapeutics Inc a privatelyheld latestage biopharmaceutical company advancing Lerodalcibep a potential best in class PCSK inhibitor for the treatment and prevention of cardiovascular disease
Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems
Researchers at the University of Torontos Donnelly Centre for Cellular and Biomolecular Research have found two enzymes that work against the chemotherapy drug gemcitabine
BioThera Solutions a commercialstage biopharmaceutical company developing innovative therapies and biosimilars and SteinCares one of Latin Americas leading specialty healthcare companies announced today a new licensing agreement
University of Queensland researchers have discovered how the onswitch for the bodys inflammation machinery can get stuck and cause rare genetic inflammatory diseases Professor Kate Schroder and her team at UQs Institute for Molecular Bioscience
